Preprocedural neutrophil-to-lymphocyte ratio: A novel predictor of permanent pacemaker implantation in self-expandable vs balloon-expandable valve cohorts following transcatheter aortic valve implantation
Haitham Abu Khadija MD , Mohammad Alnees MD , Omar Ayyad MD , Gera Gandelman MD , Gal Sella MD , Nizar Abu Hamdeh MD , Amir Haim MD , Yazan Hamdan MD , Alena Kirzhner MD , Abdalaziz Darwish MD , Duha Najajra MD , Tal Schiller MD , Alex Blatt MD , Jacob George MD
{"title":"Preprocedural neutrophil-to-lymphocyte ratio: A novel predictor of permanent pacemaker implantation in self-expandable vs balloon-expandable valve cohorts following transcatheter aortic valve implantation","authors":"Haitham Abu Khadija MD , Mohammad Alnees MD , Omar Ayyad MD , Gera Gandelman MD , Gal Sella MD , Nizar Abu Hamdeh MD , Amir Haim MD , Yazan Hamdan MD , Alena Kirzhner MD , Abdalaziz Darwish MD , Duha Najajra MD , Tal Schiller MD , Alex Blatt MD , Jacob George MD","doi":"10.1016/j.hroo.2025.03.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Transcatheter aortic valve implantation (TAVI) is the preferred treatment for severe aortic stenosis. This study examines the neutrophil-lymphocyte ratio (NLR) as a predictor of permanent pacemaker implantation (PPI) outcomes, comparing self-expandable valves (SEVs) and balloon-expandable valves (BEVs).</div></div><div><h3>Objective</h3><div>This study aims to evaluate the effectiveness of the NLR in predicting PPI outcomes in patients undergoing TAVI with SEVs and BEVs.</div></div><div><h3>Methods</h3><div>This retrospective cohort study at Kaplan Medical Center analyzed 305 patients with severe symptomatic aortic stenosis referred for TAVI from January 2010 to December 2019. Data on baseline characteristics, laboratory results, and clinical outcomes were collected, including NLR and PPI rates. Two logistic regression models were developed to identify predictors of TAVI-PPI outcomes for SEV and BEV cohorts.</div></div><div><h3>Results</h3><div>In the SEV cohort, 59 of 199 patients (29.6%) required PPI, compared with 15 of 106 patients (14.2%) in the BEV cohort. The receiver operating characteristic (ROC) curve for SEV showed an area under the curve (AUC) of 0.70, indicating predictive ability of the NLR for TAVI-PPI outcomes. The BEV cohort had a lower AUC of 0.40 (<em>P</em> = .03). In the SEV model, significant predictors included NLR (odds ratio [OR]: 1.146, <em>P</em> =.040) and total protein levels (OR: 0.012, <em>P</em> = .029). In the BEV model, the QTc interval was significant (OR: 1.023, <em>P</em> = .018).</div></div><div><h3>Conclusion</h3><div>The NLR significantly predicts permanent pacemaker implantation after TAVI, especially for SEVs, but less for BEVs.</div></div>","PeriodicalId":29772,"journal":{"name":"Heart Rhythm O2","volume":"6 6","pages":"Pages 766-780"},"PeriodicalIF":2.5000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart Rhythm O2","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666501825000893","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Transcatheter aortic valve implantation (TAVI) is the preferred treatment for severe aortic stenosis. This study examines the neutrophil-lymphocyte ratio (NLR) as a predictor of permanent pacemaker implantation (PPI) outcomes, comparing self-expandable valves (SEVs) and balloon-expandable valves (BEVs).
Objective
This study aims to evaluate the effectiveness of the NLR in predicting PPI outcomes in patients undergoing TAVI with SEVs and BEVs.
Methods
This retrospective cohort study at Kaplan Medical Center analyzed 305 patients with severe symptomatic aortic stenosis referred for TAVI from January 2010 to December 2019. Data on baseline characteristics, laboratory results, and clinical outcomes were collected, including NLR and PPI rates. Two logistic regression models were developed to identify predictors of TAVI-PPI outcomes for SEV and BEV cohorts.
Results
In the SEV cohort, 59 of 199 patients (29.6%) required PPI, compared with 15 of 106 patients (14.2%) in the BEV cohort. The receiver operating characteristic (ROC) curve for SEV showed an area under the curve (AUC) of 0.70, indicating predictive ability of the NLR for TAVI-PPI outcomes. The BEV cohort had a lower AUC of 0.40 (P = .03). In the SEV model, significant predictors included NLR (odds ratio [OR]: 1.146, P =.040) and total protein levels (OR: 0.012, P = .029). In the BEV model, the QTc interval was significant (OR: 1.023, P = .018).
Conclusion
The NLR significantly predicts permanent pacemaker implantation after TAVI, especially for SEVs, but less for BEVs.